Qyuns Therapeutics Co., Ltd. Class H (HK:2509) has released an update.
Qyuns Therapeutics Co., Ltd. conducted its Annual General Meeting (AGM) on May 31, 2024, with unanimous approval of all resolutions, including the board reports and profit distribution plan for 2023. Shareholders representing over 59% of the voting shares attended, and KPMG was appointed as the company’s auditor until the next AGM. Notably, there were no votes against any proposals, reflecting strong shareholder support for the company’s direction.
For further insights into HK:2509 stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
